Are there negative CNS impacts of aluminum adjuvants used in vaccines and immunotherapy? - Wikidata - wikimedia - TriplyDB

Are there negative CNS impacts of aluminum adjuvants used in vaccines and immunotherapy?

Are there negative CNS impacts of aluminum adjuvants used in vaccines and immunotherapy?

http://www.wikidata.org/entity/Q38271876

about

Behavioral abnormalities in female mice following administration of aluminum adjuvants and the human papillomavirus (HPV) vaccine Gardasil.Comparative Safety of Vaccine Adjuvants: A Summary of Current Evidence and Future Needs

P2860

Q34677865-A29B8900-C4ED-4247-9E7A-6E200778D076 Q36191001-E106118F-C485-4B3D-8E06-11918B3AE322

P2860

Are there negative CNS impacts of aluminum adjuvants used in vaccines and immunotherapy?

http://www.wikidata.org/entity/Q38271876

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年学术文章

@wuu

2014年学术文章

@zh-cn

2014年学术文章

@zh-hans

2014年学术文章

@zh-my

2014年学术文章

@zh-sg

2014年學術文章

@yue

2014年學術文章

@zh

2014年學術文章

@zh-hant

name

Are there negative CNS impacts of aluminum adjuvants used in vaccines and immunotherapy?

@en

type

label

Are there negative CNS impacts of aluminum adjuvants used in vaccines and immunotherapy?

@en

prefLabel

Are there negative CNS impacts of aluminum adjuvants used in vaccines and immunotherapy?

@en

P1433

Q38271876-3D95C7A6-9CBA-42E2-B1BA-5BC638E9635B

P1476

Q38271876-2DA6BB06-F332-4736-9AB1-F8E99E31CCBB

P2093

Q38271876-76F6A36B-A8BB-4BE4-8A8A-6068321E8C68

P2860

Q38271876-00B4B7F2-CF19-4863-9E8E-975804F76962

Q38271876-01C10DB0-490D-4F6A-B2F8-C30D54136FFF

Q38271876-024CC1D9-E590-4DB9-A0C9-F06ADF2537D5

Q38271876-03683FC1-CDE6-44B5-86E7-B339AFDE8855

Q38271876-048CE667-B7EE-4441-B890-490D0BE9B594

Q38271876-055784F1-8F21-4FFC-8C32-20800513EA96

Q38271876-05E7BDA2-4E81-475E-8E9B-6EB41238932A

Q38271876-0A9ECB99-A368-4E40-AEB2-47A64E4C70AF

Q38271876-0B76415E-EB63-4CD6-826F-90A457BEC0DC

Q38271876-108633AD-3A5D-4B81-9137-582625FF7EBA

P304

Q38271876-8864608B-B28B-430A-A5AB-2051F6147FCC

P31

Q38271876-83A0D0D7-8FED-4175-8258-D4DB6E8860B8

P356

Q38271876-3D418215-061D-4C84-8A71-92AFDC5A53AA

P433

Q38271876-F04496AA-2644-45B5-8AE3-C83B597528F1

P478

Q38271876-C55AF064-1757-40E4-A887-7503342A5D41

P50

Q38271876-10BBAB22-D3EE-4196-98A8-5ABEEE86E3E5

Q38271876-CF8BA14D-F777-4830-A3CA-B21E20A8BF24

P577

Q38271876-24782312-A493-4A68-A858-7D7B9D16220E

P5875

Q38271876-FB61E6C4-EA69-4D04-9776-81AEFFC6647C

P698

Q38271876-B01849E8-4AB0-403E-A4CF-585649D81EB0

P921

Q38271876-6e9ecdc5-28e8-43f1-9dba-9c4b0e933a21

P356

P1433

P1476

Are there negative CNS impacts of aluminum adjuvants used in vaccines and immunotherapy?

@en

P2093

Dan Li

http://www.w3.org/2001/XMLSchema#string

P2860

Finishing the euchromatic sequence of the human genome

Aluminum bioavailability from basic sodium aluminum phosphate, an approved food additive emulsifying agent, incorporated in cheese

Mild cognitive impairment: clinical characterization and outcome

Aluminum salts in vaccines--US perspective

Chronic fatigue syndrome: clinical condition associated with immune activation

Aluminum-induced neurotoxicity: alterations in membrane function at the blood-brain barrier

Aluminum adjuvant linked to Gulf War illness induces motor neuron death in mice

Assessment of infantile mineral imbalances in autism spectrum disorders (ASDs)

AS03 adjuvanted AH1N1 vaccine associated with an abrupt increase in the incidence of childhood narcolepsy in Finland

Autism and environmental genomics

P304

1055-1071

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2217/IMT.14.81

http://www.w3.org/2001/XMLSchema#string

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

6

http://www.w3.org/2001/XMLSchema#string

P50

Lucija Tomljenovic

P577

2014-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

268880246

http://www.w3.org/2001/XMLSchema#string

P698

25428645

http://www.w3.org/2001/XMLSchema#string

P921